8,456 peer-reviewed studies, each with a short note written from its published abstract: what kind of study it was, who took part, what was measured and what the authors reported. Observational studies show associations, not proof.
People assigned to a diet, food or program and measured.
2019 / Randomized controlled trial
Fifty-three healthy omnivore subjects were randomized to a controlled unsupplemented vegan diet (n = 26) or a meat-rich diet (n = 27) for 4 weeks. Holotranscobalamin (holo-TC) decreased significantly in the vegan diet group compared to the meat-rich diet group after four weeks, and lower intake of vitamin B12 in the vegan group was mirrored by lower serum vitamin B12 and reduced holo-TC. Metabolites MMA and tHcy were unaffected, and body weight remained stable in both groups. The vegan intervention also led to a significant reduction of cholesterol intake.
Lederer AK, Hannibal L, Hettich M, et al. Nutrients, 2019. PMID 31752105
2019 / Randomized controlled trial
Thirty adult men completed a 24-hour water-only fast on the same day of the week for three subsequent weeks, receiving placebo or a bitter hops-based appetite suppressant (Amarasate) at high (250 mg) or low (100 mg) doses at 16 and 20 hours into the fast. From 18 to 24 hours of the fast, both high- and low-dose groups had a statistically significant (p < 0.05) greater than 10% reduction in hunger compared with placebo. Furthermore, the expected lunchtime rise in hunger seen at 12:00 h in the placebo group was absent in both hops extract treatment groups.
Walker E, Lo K, Tham S, et al. Nutrients, 2019. PMID 31766216
2019 / Randomized controlled trial
In a randomized trial, 70 healthy Japanese adults with a BMI between 23 and 30 consumed 9 grams daily of either quercetin-rich onion powder or placebo for 12 weeks. Visceral fat area did not differ significantly between the groups overall, though it was lower with onion powder in participants with low HDL cholesterol. Alanine aminotransferase levels were also significantly reduced in the onion powder arm compared to placebo.
Nishimura M, Muro T, Kobori M, et al. Nutrients, 2019. PMID 31905615
2018 / Randomized crossover trial
In a randomized crossover trial with 13 healthy adults, adding two portions of cooked broccoli to mashed potato led to lower early postprandial blood glucose and insulin surges than potato alone. The broccoli-potato combination reduced peak glucose, incremental peak, and 30-minute incremental area under the curve for both markers. However, adding isolated broccoli fibre or cellulose did not alter post-meal curves compared with potato eaten by itself.
Ballance S, Knutsen SH, Fosvold ØW, et al. Eur J Nutr, 2018. PMID 27655525
2018 / Controlled trial
Fifteen healthy females were evaluated for mood, cognition, and whole-brain MR spectroscopic imaging before and after 72 hours of fasting, and compared with 15 age-matched non-fasting females. After fasting, mood scores significantly increased. Glx decreased across all nine brain regions examined, tCho decreased in eight, NAA in four, and tCr in one, with Glx showing the greatest change and the frontal lobes being the most affected brain region.
Ding XQ, Maudsley AA, Schweiger U, et al. J Cereb Blood Flow Metab, 2018. PMID 28273723
2018 / Double-blind randomized controlled trial
A double-blind clinical trial evaluated the effect of vitamin D supplementation on sleep in 89 participants aged 20-50 years with sleep disorders (44 in the intervention group and 45 in the placebo group). The intervention group received a 50,000-unit vitamin D supplement once every two weeks for 8 weeks, while the control group received a placebo. At the end of the study, the sleep score (PSQI) was significantly reduced in vitamin D recipients compared with placebo recipients (P < 0.05), even after adjusting for confounding variables (P < 0.05).
Majid MS, Ahmad HS, Bizhan H, et al. Nutr Neurosci, 2018. PMID 28475473
2018 / 2-year prospective randomized trial
In a 2-year randomized trial, 70 healthy postmenopausal overweight or obese women were assigned to a Paleolithic-type diet (PD, n=35) or a diet based on Nordic Nutrition Recommendations (NNR, n=35). At baseline, median 24-h urinary iodine concentration (24-UIC, 71.0 μg/l) and excretion (24-UIE, 134.0 μg/d) were similar between groups. After 6 months, 24-UIC fell to 36.0 μg/l (P=0.001) and 24-UIE dropped to 77.0 μg/d (P=0.001) in the PD group, while levels remained unaltered in the NNR group. Free thyroxin, TSH, and free triiodothyronine (FT3) were generally similar between groups, though FT3 was lower in the PD group at 6 months.
Manousou S, Stål M, Larsson C, et al. Eur J Clin Nutr, 2018. PMID 28901333
2018 / Double-blind, counterbalanced crossover trial
Fourteen male athletes performed isokinetic and maximal isometric knee extensions with and without taurine (40 mg/kg body mass) in a double-blind, counterbalanced design. In noncaffeine consumers, taurine significantly reduced isokinetic first peak torque (-16.1%, P = 0.013), best peak torque (-5.0%, P = 0.016), first power output (-17.7%, P = 0.015), and best power output (-8.0%, P = 0.008), as well as isometric first (-5.1%, P = 0.002) and best peak torque (-4.3%, P = 0.032). In caffeine-deprived caffeine consumers, taurine improved best isokinetic power (5.2%, P = 0.045) but had no effect on isometric variables. Taurine ingestion increased blood taurine levels without altering plasma amino acid levels.
Lim ZIX, Singh A, Leow ZZX, et al. Med Sci Sports Exerc, 2018. PMID 28945675
2018 / Randomized crossover trial
During a three-day randomized crossover trial in 21 healthy participants, an isocaloric vegan diet lowered triglycerides, insulin, bile acids, and insulin resistance assessed by HOMA-IR (p < 0.05). It also raised magnesium levels and altered branched-chain amino acid metabolism compared with an omnivorous regimen. Fiber and polyunsaturated fats correlated inversely with triglycerides, insulin, and HOMA-IR.
Draper CF, Vassallo I, Di Cara A, et al. Mol Nutr Food Res, 2018. PMID 29087622
2018 / Randomized crossover trial
In a randomized crossover trial, 30 healthy individuals (15 with a family history of type 2 diabetes) consumed isocaloric high-cholesterol/high-fat (HChF) and low-cholesterol/low-fat (LChF) diets for 14 days each. Shifting from HChF to LChF had no effect on body weight but significantly reduced mean glucose (-5%, P = 0.01) and improved beta cell function, including glucose sensitivity (+17%, P = 0.01), fasting insulin secretion (+20%, P = 0.02), and potentiation (+19%, P = 0.03). Insulin sensitivity improved (+7%, P = 0.048) specifically in offspring of individuals with type 2 diabetes.
Tricò D, Trifirò S, Mengozzi A, et al. J Clin Endocrinol Metab, 2018. PMID 29095990
2018 / Controlled trial
Participants (n = 51) were provided an 825-calorie lunch eaten either while listening to an audio clip prompting focus on sensory properties of food or in silence, followed by a snack offered 2 hours later. While lunch intake did not differ significantly between groups, the mindful eating group consumed significantly fewer snack calories than controls (mean = 112.30 calories, SD = 70.24 vs. mean = 203.20 calories, SD = 88.05; Cohen's d = 1.14). This effect was not explained by enhanced memory for lunch and occurred regardless of gender or interoceptive awareness, with no significant moderation by reward sensitivity.
Seguias L, Tapper K Appetite, 2018. PMID 29104106
2018 / Randomized crossover trial
Eighteen healthy volunteers completed two study visits following an overnight fast, receiving tablets containing either 6845 mg sodium propionate or 4164 mg sodium chloride over 180 minutes in random order. REE and substrate oxidation were measured by indirect calorimetry. Oral sodium propionate administration significantly increased REE (0.045 ± 0.020 kcal/min; P = .036) and whole-body lipid oxidation (0.012 ± 0.006 g/min; P = .048), independent of glucose and insulin changes.
Chambers ES, Byrne CS, Aspey K, et al. Diabetes Obes Metab, 2018. PMID 29134744
2018 / Randomized crossover trial
A double-blind, randomized crossover trial evaluated 13 trained male runners completing a 1-mile race 60 minutes after consuming 0.09 g/kg caffeinated coffee, decaffeinated coffee, or placebo. Running time was 1.3% faster with coffee (04:35.37) than decaffeinated coffee (04:39.14; P = .018; 95% CI, -0.11 to -0.01) and 1.9% faster than placebo (04:41.00; P = .006; 95% CI, -0.15 to -0.03). Differences between decaffeinated coffee and placebo were trivial.
Clarke ND, Richardson DL, Thie J, et al. Int J Sports Physiol Perform, 2018. PMID 29140142
2018 / Randomized controlled dose-response crossover trial
In a randomized, controlled, dose-response crossover trial, 20 young, healthy Chinese men consumed isocaloric, macronutrient-matched test meals of white rice with three doses of curry made with mixed spices and vegetables. Plasma total GLP-1 concentrations were measured at baseline and for up to 3 hours postprandially. Total AUC of plasma GLP-1 concentrations, adjusted for baseline, increased in a dose-dependent manner: adjusted mean (±SEM) of 10568.3 ± 1267.9 pg ml-1.min for Dose 0 Control, 12391.8 ± 1333.94 pg ml-1.min for Dose 1 Curry, and 13905.1 ± 1267.6 pg ml-1.min for Dose 2 Curry (p = 0.019).
Haldar S, Chia SC, Henry CJ Eur J Clin Nutr, 2018. PMID 29284788
2018 / Secondary analysis of a randomized controlled trial
Thirty-four obese participants completed 12 months of alternate-day fasting and were categorized by achieving at least 5% weight loss or under 5% weight loss. The high-loss group experienced increased fullness (p = 0.04) and decreased hunger (p = 0.03). They also raised dietary protein from 15% to 20% of energy intake (p = 0.04) and adhered more closely to fast-day caloric targets.
Kroeger CM, Trepanowski JF, Klempel MC, et al. Nutr Health, 2018. PMID 29353535
2018 / Parallel-design randomized controlled trial
Forty-two normal-weight healthy short sleepers were randomized to a sleep extension group receiving a sleep hygiene behavioral consultation (n = 21) or a control group maintaining habitual short sleep (n = 21) for 4 weeks. Compared with controls, the sleep extension group significantly increased time in bed (0:55 h:mm), sleep period (0:47 h:mm), and sleep duration (0:21 h:mm). Sleep extension led to a significant reduction in free sugar intake (-9.6 g vs. 0.7 g in controls; P = 0.042), with no significant differences observed between groups in markers of energy balance or cardiometabolic health.
Al Khatib HK, Hall WL, Creedon A, et al. Am J Clin Nutr, 2018. PMID 29381788
2018 / Randomized controlled trial
A randomized, double-blind, placebo-controlled trial evaluated d-allulose at 4 g or 7 g twice daily against sucralose in 121 Korean adults with BMI ≥ 23 kg/m². Body fat percentage and body fat mass decreased following allulose supplementation. Compared with placebo, the high-dose group demonstrated significant reductions in BMI along with total abdominal and subcutaneous fat areas on CT scans, with no differences in lipid profiles or nutrient intake.
Han Y, Kwon EY, Yu MK, et al. Nutrients, 2018. PMID 29385054
2018 / Open-label, non-randomized, controlled study
An open-label, non-randomized controlled study evaluated a 1-year continuous care intervention (CCI) delivering remote care, biometric feedback, and nutritional ketosis versus usual care (UC) in adults with type 2 diabetes. In the CCI group, HbA1c declined from 7.6 ± 0.09% to 6.3 ± 0.07%, weight decreased by 13.8 ± 0.71 kg, and non-metformin diabetes medication prescriptions fell from 56.9 ± 3.1% to 29.7 ± 3.0% (all P < 1.0 × 10^-16). Insulin was reduced or stopped in 94% of users, sulfonylureas were eliminated, and improvements were observed in HOMA-IR, hsCRP, and triglycerides, alongside a 10% increase in LDL-C; usual care participants had no significant biomarker or medication changes.
Hallberg SJ, McKenzie AL, Williams PT, et al. Diabetes Ther, 2018. PMID 29417495
2018 / Randomized controlled trial
Overweight or obese adults were randomized to an 8-week caloric restriction diet alone (CR, n = 15) or combined with sleep restriction on 5 nights per week (CR + SR, n = 21). Both groups had similar total weight, lean mass, and fat mass loss. However, the proportion of total mass lost as fat was significantly greater in the CR group (p = 0.016). Resting respiratory quotient decreased only in CR (p = 0.033), and fasting leptin concentration decreased only in CR + SR (p = 0.029).
Wang X, Sparks JR, Bowyer KP, et al. Sleep, 2018. PMID 29438540
2018 / Repeated-measures test-retest trial
Eleven participants completed two 24-hour fasts following a 3-day standardized weight-maintenance diet to evaluate test-retest reliability of hunger variables and subsequent energy intake. At 16 hours of fasting, ICCs for all hunger-related assessments were significant (r = 0.67-0.91; p ≤ 0.05), but reliability varied over time, with average ICCs of 0.81 for fullness, 0.74 for prospective food consumption (PFC), 0.67 for energy, 0.44 for desire to eat (DTE), and 0.36 for hunger. Average post-fast energy compensation was 60% of weight-maintenance needs (ranging 7 to 110%) and correlated with changes in PFC, hunger, and DTE, but not body fat percentage. After fasting, percent energy intake from fat and protein increased (29.9% to 37.3% and 13.8% to 16.8%), while carbohydrate intake decreased (56.4% to 46.0%).
Tinsley GM, Moore ML, Graybeal AJ Physiol Behav, 2018. PMID 29438660
2018 / Randomized controlled pilot study
An 8-week randomized controlled pilot study examined the impact of energy distribution timing within a hypocaloric, three-meal diet in 8 participants. Participants were assigned to either a Morning pattern (50%, 30%, and 20% of kcal at breakfast, lunch, and dinner) or an Evening pattern (20%, 30%, and 50% of kcal at breakfast, lunch, and dinner). Percent weight loss and regularity of sleep onset and wake times were significantly greater for Morning compared to Evening (p < 0.05). The authors note the need for longer studies in free-living participants with time-stamped dietary assessments.
Raynor HA, Li F, Cardoso C Physiol Behav, 2018. PMID 29471076
2018 / Randomized trial
Twenty-seven overweight or obese adults were randomized to intermittent energy restriction (IER, n=15) or continuous energy restriction (CER) until achieving 5% weight loss, followed by 7 days of weight stabilization. There was no significant difference in time to 5% weight loss (median 59 d vs 73 d, P=0.246) or body composition changes between groups. Neither diet significantly altered postprandial glycaemia (P=0.266), and insulinaemia was reduced comparatively (P=0.903). However, IER led to a significantly greater relative reduction in postprandial TAG responses (106 to 68 mmol×360 min/l) compared to CER (117 to 130 mmol×360 min/l; P=0.045), and a trend toward a greater reduction in C-peptide (P=0.057).
Antoni R, Johnston KL, Collins AL, et al. Br J Nutr, 2018. PMID 29508693
2018 / Randomized controlled crossover trial
In a randomized, double-blind trial, 101 male athletes completed a 10-km cycling time trial with 0, 2, or 4 mg/kg of caffeine. Overall, 4 mg/kg decreased cycling duration by 3% versus placebo (P = 0.01), but a significant caffeine-gene interaction occurred (P < 0.0001). Cycling time decreased at 2 mg/kg (-4.8%) and 4 mg/kg (-6.8%) in AA genotypes, showed no change in AC genotypes, and lengthened by 13.7% at 4 mg/kg in CC genotypes.
Guest N, Corey P, Vescovi J, et al. Med Sci Sports Exerc, 2018. PMID 29509641
2018 / Randomized clinical trial (2x2 factorial)
A 2x2 factorial randomized trial assigned 92 functionally limited older men for 6 months to controlled diets of 0.8 or 1.3 g/kg/d of protein, paired with weekly testosterone or placebo. Changes in lean body mass (0.31 kg; 95% CI, -0.46 to 1.08 kg; P = .43), appendicular lean mass, muscle strength, physical function, and well-being did not differ between protein levels, regardless of testosterone use. However, fat mass decreased significantly more with higher protein intake compared to the RDA group (difference, -1.12 kg; 95% CI, -2.04 to -0.21; P = .02).
Bhasin S, Apovian CM, Travison TG, et al. JAMA Intern Med, 2018. PMID 29532075